Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
about
Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic AnalysisThe genetics of multiple sclerosis: review of current and emerging candidatesFocused examination of the intestinal epithelium reveals transcriptional signatures consistent with disturbances in enterocyte maturation and differentiation during the course of SIV infectionEpigenetic Drugs for Multiple SclerosisBromodomains: Translating the words of lysine acetylation into myelin injury and repairThe Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte DifferentiationExperimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin DamagePotential of epigenetic therapies in non-cancerous conditions.Epigenetics and autoimmune diseases.An integrated approach to design novel therapeutic interventions for demyelinating disordersOlig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.Epigenetic mechanisms in neurological diseaseEpigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatmentPleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells.Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.Systematic approaches to central nervous system myelin.Epigenetic changes in patients with multiple sclerosis.Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities.The potential role of epigenetic modifications in the heritability of multiple sclerosis.Epigenetics of multiple sclerosis: an updated review.Glial epigenetics in neuroinflammation and neurodegeneration.Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.Oligodendroglial Development: New Roles for Chromatin Accessibility.Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).Epigenomics of autoimmune diseases.Canonical Wnt signaling in the oligodendroglial lineage--puzzles remain.Interplay between transcriptional control and chromatin regulation in the oligodendrocyte lineage.Epigenetics in NG2 glia cells.Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationInhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Epigenetic Modifications and Therapy in Multiple Sclerosis.Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.Promoting return of function in multiple sclerosis: An integrated approach.Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage.Sox2 is essential for oligodendroglial proliferation and differentiation during postnatal brain myelination and CNS remyelination.Epigenetic modifications in brain and immune cells of multiple sclerosis patients.Chromatin remodeling and epigenetic regulation of oligodendrocyte myelination and myelin repair.
P2860
Q26774368-F77D22E5-A76A-475E-9404-872F2E173B83Q26825782-B8CA8C95-7E74-4F44-9D2E-E24ED322232CQ27331953-779342B6-0835-47DD-A98A-458F45259D10Q28076395-AAAD0C07-18CF-4815-BEB6-B9CFDEBB01C5Q28268681-DD502A60-4803-419C-AEE5-BF271C35CA00Q30360840-2195B163-3B9E-475D-963C-D569AB1B6B7CQ33838894-8DFEB867-80B7-4570-970E-0A0F2CD7CE90Q34742578-AAAF1621-8371-4B7E-A0A6-B35B627EFC5EQ35867015-82F63920-CC26-447F-9103-553486DB4A51Q36059972-FA551AE8-F2A9-44B1-8C28-02AC41214A2CQ36339174-23E76AFE-5148-47C9-9555-4FDA2ECBFE46Q36682567-9193411C-CEC1-4796-AA82-6A0A249F27C9Q36948933-AF323064-0F06-4FC1-BB26-EC133ABAF084Q36979734-3FB71D65-AAFC-49CB-AA33-6DB26A79E354Q37602769-E6D74E30-5844-4A11-AAED-D1BC35F99FBCQ37996290-48EE7E00-B995-4AEC-A8A5-FF3151A2049EQ38061010-E9017CCB-FA18-440A-B788-CEDC1D3F8C1CQ38094663-396720D3-3BF5-42D4-B845-22B1DB9A358CQ38184977-72756AA8-5392-4C9B-A3EA-0CC11E4D5615Q38197927-9B45E2F3-7B12-4B41-9E20-E8DF5C77E1FBQ38197952-3D5FB209-5C4F-462D-BD95-D1298D784AF8Q38297582-25D8DC53-554D-4EAB-8A3C-7D70484499AAQ38309342-556EF8B3-588B-465F-9E43-4842F9E9485FQ38314584-115F2C44-571F-45E6-9CC6-3AAE0A6BBD88Q38380209-5A00644E-43AE-4421-96ED-96FF7CF77A59Q38381699-E21CF6DE-F46F-4761-B2C0-9FEF1661ED9DQ38477392-2F61A58E-253A-482A-8D91-924F16C4DA58Q38532591-DE374D3C-94AA-4B84-8AB6-4814CE88D3A1Q38543597-2BD48740-F956-41E1-B4B1-2D277315A7F5Q38654321-B7601347-0634-43C5-9A42-E5C0FF53B96AQ38789322-110A71B7-0992-464D-928F-88351DC9DF53Q38833038-DD22E9CD-E257-40A2-AB01-39ED2E74C7AEQ38887611-124C4F39-4084-4764-B0C1-19E02AA15E0DQ39825327-12D0B3B7-2FF4-4CCE-B75C-170F4DAF6540Q41872258-5A47CA84-7595-4795-99F7-EBE13A861F5EQ42000292-A31C807C-5A3F-43F0-9224-D71CA99B2E11Q46448356-0A99828F-26B8-4341-B8C7-D43A1F90A668Q47863799-E93CD03D-0ED1-468E-9BB7-6C4B46F5CE94Q47880039-E4087DB1-1C92-44AA-BD74-1564E782DB8FQ47907953-BEC3C954-4926-4435-8711-C157132CF355
P2860
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@ast
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@en
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@nl
type
label
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@ast
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@en
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@nl
prefLabel
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@ast
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@en
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@nl
P2093
P2860
P1476
Changed histone acetylation pa ...... ly multiple sclerosis lesions.
@en
P2093
Fabrizio Mastronardi
Gerardo López-Rodas
Tanja Kuhlmann
Wolfgang Bruck
Xiomara Pedre
P2860
P304
P356
10.1523/JNEUROSCI.4507-10.2011
P407
P577
2011-03-01T00:00:00Z